Sagimet Biosciences Inc.
Company Stats
- Market Cap
- $614.1M
- as of Sep 30, 2026
- Shares Outstanding
- 62.2M
- Free Float
- 70.6%
Income Statement
- Operating Income
- -$56.9M
- Net Income
- -$51.0M
Balance Sheet
- Cash & Equivalents
- $35.0M
Returns & Capital
- SBC, 3Y Avg
- $5.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2023 | $2.0M | — | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges